BUZZ-West Pharma shares rise after raising annual performance forecast

October 29 - ** Medical device manufacturer West Pharmaceutical Services (WST.N) saw its share price rise by 6.53% in pre-market trading to $430

** The company raised its annual adjusted earnings per share forecast from the previous range of $8.85–$9.05 to $9.38–$9.48

** The company raised its full-year revenue forecast from the previous estimate of $3.35 billion–$3.38 billion to $3.41 billion–$3.42 billion

** The company reported third-quarter adjusted earnings per share of $2.66, exceeding analysts' expectations of $2.19 — LSEG

** The company reported third-quarter revenue of $874.5 million, surpassing analysts' expectations of $825.7 million — LSEG compiled data

** As of the previous trading day’s close, the stock had gained about 47% year-to-date

(To facilitate non-English speakers, Reuters provides automated translations of its reports into several other languages. As automated translations may be inaccurate or lack necessary context, Reuters does not guarantee the accuracy of automated translation texts and provides them for readers’ convenience only. Reuters accepts no responsibility for any damage or loss arising from the use of automated translation features.)